Frank Stokes Castle Biosciences Inc (CSTL) insider trading activity

Frank Stokes is Chief Financial Officer of CASTLE BIOSCIENCES INC. Currently has a direct ownership of 35,319 shares of CSTL, which is worth approximately $765,715. The most recent transaction as insider was on Feb 20, 2025, when has been sold 8,046 shares (Common Stock) at a price of $26.7 per share, resulting in proceeds of $214,828. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.3K

14.59% 3M change

10.7% 12M change

Total Value Held $765,715

Frank Stokes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 20 2025	SELL Open market or private sale	$214,828 $26.7 p/Share	8,046 Reduced 18.55%	35,319 Common Stock
Dec 10 2024	SELL Payment of exercise price or tax liability	$108,830 $29.63 p/Share	3,673 Reduced 7.81%	43,365 Common Stock
Dec 10 2024	BUY Exercise of conversion of derivative security	-	8,169 Added 15.04%	46,138 Common Stock
Dec 09 2024	SELL Payment of exercise price or tax liability	$203,109 $30.91 p/Share	6,571 Reduced 14.46%	38,869 Common Stock
Dec 09 2024	BUY Exercise of conversion of derivative security	-	14,617 Added 24.34%	45,440 Common Stock
Nov 15 2024	SELL Open market or private sale	$208,659 $30.14 p/Share	6,923 Reduced 18.34%	30,823 Common Stock
Aug 09 2024	SELL Payment of exercise price or tax liability	$75,714 $26.83 p/Share	2,822 Reduced 6.96%	37,746 Common Stock
Aug 09 2024	BUY Grant, award, or other acquisition	-	9,745 Added 19.37%	40,568 Common Stock
Aug 07 2024	SELL Open market or private sale	$256,700 $25.67 p/Share	10,000 Reduced 24.5%	30,823 Common Stock
Dec 10 2023	SELL Payment of exercise price or tax liability	$48,125 $20.17 p/Share	2,386 Reduced 5.69%	39,551 Common Stock
Dec 10 2023	BUY Exercise of conversion of derivative security	-	8,170 Added 16.91%	40,135 Common Stock
Dec 09 2023	SELL Payment of exercise price or tax liability	$86,105 $20.17 p/Share	4,269 Reduced 11.22%	33,767 Common Stock
Dec 09 2023	BUY Exercise of conversion of derivative security	-	14,617 Added 27.76%	38,036 Common Stock
Apr 04 2023	BUY Exercise of conversion of derivative security	$13,520 $3.38 p/Share	4,000 Added 14.59%	23,419 Common Stock
Dec 10 2022	SELL Payment of exercise price or tax liability	$53,701 $22.32 p/Share	2,406 Reduced 11.49%	18,539 Common Stock
Dec 10 2022	BUY Exercise of conversion of derivative security	-	8,170 Added 28.64%	20,356 Common Stock
May 12 2022	BUY Exercise of conversion of derivative security	$13,520 $3.38 p/Share	4,000 Added 23.85%	12,775 Common Stock
Apr 26 2022	BUY Grant, award, or other acquisition	-	1,114 Added 11.27%	8,775 Common Stock
Dec 10 2021	SELL Payment of exercise price or tax liability	$36,265 $40.52 p/Share	895 Reduced 10.88%	7,330 Common Stock
Dec 10 2021	BUY Exercise of conversion of derivative security	-	2,000 Added 19.56%	8,225 Common Stock
Jun 17 2021	SELL Open market or private sale	$92,929 $73.0 p/Share	1,273 Reduced 17.7%	5,920 Common Stock
Jun 17 2021	BUY Exercise of conversion of derivative security	$3,042 $2.39 p/Share	1,273 Added 15.04%	7,193 Common Stock
Jun 16 2021	SELL Open market or private sale	$155,420 $73.07 p/Share	2,127 Reduced 26.43%	5,920 Common Stock
Jun 16 2021	BUY Exercise of conversion of derivative security	$5,084 $2.39 p/Share	2,127 Added 20.91%	8,047 Common Stock
Jun 15 2021	SELL Open market or private sale	$847,032 $73.02 p/Share	11,600 Reduced 66.21%	5,920 Common Stock

Also insider at

XGN

EXAGEN INC. Healthcare

Director

Frank Stokes

Chief Financial Officer

Friendswood, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CSTL shares.

Notify only if

Value

Insider Trading

Get notified when an Castle Biosciences Inc insider buys or sells CSTL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CASTLE BIOSCIENCES INC

Track Activities on CSTL

Account